MEB 17.4% 1.9¢ medibio limited

Ametus Study

  1. 52 Posts.
    The Ametus study shows a potential of USD100m if MEB achieves 5% of the market in the US, with the first objective test for depression. Can use existing reimbursement codes so the route to market is simplified, and they have JHU to validate the science in the US. They just keep ticking boxes....
 
watchlist Created with Sketch. Add MEB (ASX) to my watchlist
(20min delay)
Last
1.9¢
Change
-0.00(17.4%)
Mkt cap $3.938M
Open High Low Value Volume
2.2¢ 2.2¢ 1.9¢ $8.36K 432.6K

Buyers (Bids)

No. Vol. Price($)
3 676669 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 207049 1
Last update - 15.50pm 14/12/2018 (20 minute delay) ?
(live)
Last
1.9¢
  Change
-0.00 ( 9.52 %)
Open High   Low Volume
1.9¢ 1.9¢   1.9¢ 30948
Last updated 15.50pm 14/12/2018 (live) ?
MEB (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.